Potential Role of Lymphocyte CD44 in Determining Treatment Selection Between Stereotactic Body Radiation Therapy and Surgery for Early-Stage Non-Small Cell Lung Cancer
Stereotactic body radiation therapy (SBRT) versus surgery for operable early-stage non-small cell lung cancer (ES-NSCLC) remains highly debated. Herein, we used spatial proteomics to identify whether any molecular biomarker(s) associate with the efficacy of either modality, in efforts to optimize treatment selection between surgery and SBRT for this population.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Weiwei Yan, Ziyuan Ren, Xi Chen, Ran Zhang, Juncai Lv, Vivek Verma, Meng Wu, Dawei Chen, Jinming Yu Tags: Clinical Investigation Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Lung Cancer | Men | Molecular Biology | Non-Small Cell Lung Cancer | Physics | Radiation Therapy | Radiology